Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Somatostatin  (4)
  • Euglycaemic clamp  (2)
  • Obesity  (2)
  • 1
    ISSN: 1432-1440
    Keywords: Semisynthetic human insulin ; Biological potency ; Insulin hypoglycaemia ; Euglycaemic clamp
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The biological potency of semisynthetic human insulin (Actrapid HM, Novo) and purified pork insulin (Actrapid MC, Novo) was assessed in normal and diabetic subjects. The blood glucose lowering effect and the related counter-regulatory response were initially tested in six healthy subjects who received an i.v. injection of 0.15 U/kg body weight of either insulin preparation. The attained insulin levels were very similar (peak at 15 min: HM 139±7, MC 129±7 µU/ml), as well as the resulting blood glucose curves. A prolonged suppression of C-peptide values was observed after injecting both preparations. The evoked counter-regulatory response [glucagon, growth hormone (GH), cortisol and catecholamines] showed minimal differences. Prolactin secretion was almost identical after HM and MC injection. A glucose clamp study was subsequently performed in six insulin-dependent diabetic (IDD) patients. Blood glucose levels were maintained at 80 mg/dl by the artificial pancreas during a 180 min infusion of MC or HM insulin (30 mU/kg/h). The amounts of dextrose infused during the last 60 min of the study were not significantly different (121±14 vs 137±11 mg/kg/h for MC and HM, respectively). It is clear from our results that at the dose levels used in this study, the biological potency of i.v. injected HM is very similar to that of MC.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 54 (1976), S. 173-175 
    ISSN: 1432-1440
    Keywords: Somatostatin ; ACTH-Sekretion ; Nebennierenrindeninsuffizienz ; Somatostatin ; ACTH secretion ; Adrenal insufficiency
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary Somatostatin (250 µg as a bolus i.v. and 250 µg as a 1-hr infusion) was administered to 5 patients with adrenal insufficiency of different origin. In each patient a sustained, progressive fall in plasma ACTH was observed during the infusion period. The mean maximal reduction in plasma ACTH was 43.8±5.9%. After cessation of the somatostatin infusion there was a rise of plasma ACTH to starting levels within 1/2 hour. These findings suggest that somatostatin is a potent inhibitor of ACTH secretion, however, only in a condition in which glucocorticoids are lacking.
    Notes: Zusammenfassung Somatostatin (250 µg als Bolus i.v. und 250 µg als Dauerinfusion über eine Stunde) wurde 5 Patienten mit Nebennierenrindeninsuffizienz verschiedener Ätiologie gegeben. Bei jedem Patienten wurde ein anhaltender, kontinuierlicher Abfall des Plasma-ACTH während der Infusionsperiode beobachtet. Die durchschnittliche maximale Verminderung des Plasma-ACTH betrug 43,8±5,9%. Nach Beendigung der Somatostatininfusion stieg das Plasma-ACTH innerhalb einer halben Stunde wieder auf den Ausgangswert an. Diese Ergebnisse zeigen, daß Somatostatin ein potenter Inhibitor der ACTH-Sekretion ist, jedoch nur bei einem bestehenden Mangel an Glucokortikoiden.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 54 (1976), S. 977-982 
    ISSN: 1432-1440
    Keywords: Somatostatin ; Blutgerinnung ; Thrombozytenfunktion ; Somatostatin ; Blood coagulation ; Platelet function
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary The effect of short- and long-term somatostatin (GIF) administration on haemostatic function in man was investigated. The dosage programme applied in this study was 250 µg GIF as a bolus injection and 250 µg GIF/h by way of infusion. In five healthy volunteers a short-term (3 h) treatment resulted in a statistically significant drop of platelet count and impairment of platelet aggregation at the end of infusion. However, these changes were within the physiologically normal range and disappeared after two hours on all subjects. Other parameters such as bleeding time, thromboplastin and partial thromboplastin time, fibrinogen, fibrin/fibrinogen split products, plasma factor XIII, ethanol gelation test were not affected. In two patients with gastric haemorrhage and persistent amylasaemia a 67 or 120-h treatment induced no remarkable haemostatic defect. By contrast, peptic ulcer bleeding in one patient stopped 60 min after starting the GIF infusion. These studies indicated that somatostatin administration in man at the dosage programme used neither results in clinical evidence indicating bleeding tendency nor does it influence laboratory parameters in an apparent way.
    Notes: Zusammenfassung Die Beeinflussung verschiedener Haemostaseparameter beim Menschen durch Kurzund Langzeit-Anwendung von Somatostatin (GIF) wurde untersucht. Das in der Studie eingesetzte Dosierungsschema bestand aus einer intravenösen Bolusinjektion von 250 µg GIF und einer anschließenden Dauerinfusion von 250 µg GIF/h. Bei 5 gesunden, freiwilligen Probanden war nach Beendigung einer Kurzzeittherapie über 3 h ein statistisch signifikanter Abfall der Thrombozytenzahl und eine Beeinträchtigung der Thrombozytenfunktion nachweisbar. Die Veränderungen lagen jedoch innerhalb des physiologischen Normalbereiches und waren innerhalb von 2 h nach Infusionsende voll reversibel. Andere Parameter (Blutungszeit, Thromboplastinzeit und Partialthromboplastinzeit, Fibrinogen, Fibrinogen/Fibrinspaltprodukte, Blutgerinnungsfaktor XIII, Äthanoltest) wurden nicht beeinflußt. Bei 2 Patienten mit Magenblutung bzw. persistierender Amylasämie wurde die Somatostatin-Behandlung über 67 bzw. 120 h durchgeführt. Ein klinisch relevanter Haemostasedefekt war bei Therapieende labordiagnostisch nicht erkennbar. Im Fall des Patienten mit Magenblutung kam es vielmehr 60 min nach Beginn der Therapie zum Sistieren der Haemorrhagie. Die Untersuchungen haben gezeigt, daß nach Anwendung von Somatostatin beim Menschen unter Verwendung des angegebenen Dosierungsschemas weder klinische noch labordiagnostische Hinweise bestehen, die die Annahme einer klinisch relevanten, iatrogen-induzierten haemorrhagischen Diathese rechtfertigen.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 66 (1988), S. 216-222 
    ISSN: 1432-1440
    Keywords: Fat distribution ; Hyperinsulinemia ; Obesity ; Glucose tolerance ; Non-insulin dependent diabetes
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Relationship between body fat distribution, serum insulin, and glucose tolerance in obese, non-diabetic women. Recent studies suggest that hyperinsulinemia and upper body obesity are predictive factors for the development of non-insulindependent diabetes mellitus. To further characterize the relationship between body fat distribution, serum insulin, and glucose tolerance an oral glucose tolerance test was performed in 48 obese, nondiabetic women. Fasting insulin levels were correlated to both total body fat calculated as body mass index (r=0.58,p〈0.001) and upper body fat distribution expressed as waist-to-hip ratio (WHR,r=0.47,p〈0.01). In the women with upper body fat localization (WHR〉0.90) significantly higher basal and glucose-stimulated insulin concentrations were established than in the women with a lower body type of obesity (WHR〈0.78) (basal insulin 27.4±11.5 vs. 15.4±8.8 mU/l,p〈0.05, insulin area 779±320 vs. 468±237 U,p〈0.05). They also had impaired glucose tolerance (glucose area 925±139 vs. 633±147 U,p〈0.01). Fasting triglyceride concentrations were correlated both with WHR (r=0.63,p〈0.001) and fasting insulin (r=0.33,p〈0.05) but not with BMI (r=−0.02, n.s.). A positive association was found between systolic and diastolic blood pressure and both WHR (r=0.43 andr=0.44 resp.,p〈0.01) and BMI (eachr=0.35,p〈0.05). Interestingly, basal insulin was also associated with blood pressure (r=0.30,p〈0.1, andr=0.40,p〈0.01 resp.). These results suggest a close relationship between upper body obesity, hyperinsulinemia, and impaired glucose tolerance. Women with an upper body tpye of obesity also show tendencies to hypertriglyceridemia and hypertension. Obese women with upper body obesity represent a subgroup of the obesity population with an increased risk to develop type-II diabetes.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    ISSN: 1432-1440
    Keywords: Somatostatin ; Insulin ; C-peptide ; Diabetes ; Pituitary function ; Gastric acid secretion
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary A case of somatostatinoma syndrome in a 30-year-old woman is presented. Basal levels of growth hormone and of pancreatic and gastric hormones were reduced and the response of growth hormone, insulin and C-peptide to stimuli such as arginine, glucose, glibenclamide and calcium was virtually abolished. Similarly, gastric acid secretion, pancreatic exocrine function and intestinal absorption were significantly reduced. On the other hand, basal and stimulated levels of adrenocorticotropic hormone (ACTH), luteinizing hormone (LH), follicle-stimulating hormone (FSH) and thyroid-stimulating hormone (TSH) were within the normal range. Plasma somatostatin-like immunoreactivity was increased to 600 2,000 pg/ml (normal: 88–140 pg/ml). Immunocytochemical studies demonstrated the presence of somatostatin immunoreactive material in the primary tumour in the head of the pancreas and in the liver metastases. In spite of two courses of chemotherapy with streptozotocin and 5-fluorouracil the patient died due to liver failure 5 months after the first admission to hospital.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 63 (1985), S. 545-553 
    ISSN: 1432-1440
    Keywords: Type I diabetes ; Insulin resistance ; Euglycaemic clamp ; Insulin receptor binding ; Insulin antibodies
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Insulin sensitivity was assessed using the euglycaemic clamp technique in eight type I diabetic patients (after overnight blood glucose normalization with an artificial pancreas) and in six healthy subjects. Basal insulin concentrations were higher in diabetic patients (25±4 µU/ml) than in control subjects (17±1 µU/ml;P〈0.05). Insulin infusion of 0.5, 1.0, 2.0 and 5.0 mU/kg per min during subsequent 2-h periods resulted in similar mean steady-state insulin concentrations in both groups. The mean dextrose requirements during the last 40 min of each period were nevertheless decreased in diabetic patients (1.6±0.5, 3.5±0.8, 6.5±0.7, 10.2±0.7 mg/kg per min) as compared with control subjects (4.7±0.3, 8.2±0.9, 10.2±0.9, 12.4±0.9 mg/kg per min). At low insulin concentrations dextrose requirements were diminished in all diabetic subjects. At the highest insulin levels, individual dose-response curves from only four patients were within the normal range. Under basal conditions, the monocyte receptor number was significantly reduced in diabetic patients (17,500±2,800 sites/cell) as compared with control subjects (26,700±2,500 sites/cell;P〈0.05), whereas there were no differences regarding empty site affinities. Receptor data did not differ in patients with normal and decreased maximal dextrose requirements. Insulin resistance is apparently a common feature of type I diabetes at serum insulin concentrations of approximately 100 µU/ml. Normalization of the insulin effect by higher insulin concentrations is not possible in all patients. Insulin antibodies at concentrations observed in this study (〈0.16 mU/ml) do not contribute significantly to insulin resistance; receptor and postreceptor defects are possibly more important.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    ISSN: 1432-1440
    Keywords: Coronary artery disease ; Sex hormones ; Obesity ; Body fat distribution ; Angiography
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The relationship between circulating sex hormone levels and the occurrence of coronary artery disease (CAD) was studied in a group of 274 men undergoing coronary angiography. Hormone levels in men with CAD (n=200) were compared to those in men found to be free of coronary lesions (n=74). No significant differences were found for serum concentrations of estradiol, total testosterone, sex-hormone-binding globulin, free androgen index, dehydroepiandrosterone sulfate, or cortisol between the two groups. Serum androgens were negatively correlated to age in both groups, whereas estradiol was weakly associated with total cholesterol in the group of men without CAD. No consistent associations were detected between sex hormone levels and the degree of obesity or the distribution of body fat, the latter being assessed by the ratio of waist-to-hip circumferences. The results of this study do not support a significant role of sex steroid hormones in coronary artery disease in men.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    ISSN: 1433-8580
    Keywords: H2-Receptor ; Somatostatin ; Pancreatic polypeptide ; Gastrin ; Insulin
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The effect of histamine H2-receptor stimulation via the infusion of impromidine was assessed with regard to postprandial plasma insulin, pancreatic polypeptide (PP), somatostatin, and gastrin levels. The effect of impromidine was assessed in the postprandial state during a liver extract/sucrose test meal which had a buffer capacity to maintain the intragastric pH at a constant level for the time impromidine was infused. Postprandial plasma insulin and gastrin levels were not changed by impromidine (10µg/kg·h−1). Plasma somatostatin levels rose significantly, whereas the postprandial increase of plasma PP levels was attenuated. The effects on somatostatin and PP were antagonized by the infusion of cimetidine, a specific histamine H2-receptor blocker. In conclusion the present data demonstrate that in the postprandial state activation of H2-receptors stimulates somatostatin and inhibits PP release while insulin and gastrin release are not affected.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...